Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

New developments in clinical aspects of lymphatic disease

Identifieur interne : 004847 ( Pmc/Corpus ); précédent : 004846; suivant : 004848

New developments in clinical aspects of lymphatic disease

Auteurs : Peter S. Mortimer ; Stanley G. Rockson

Source :

RBID : PMC:3938261

Abstract

The lymphatic system is fundamentally important to cardiovascular disease, infection and immunity, cancer, and probably obesity — the four major challenges in healthcare in the 21st century. This Review will consider the manner in which new knowledge of lymphatic genes and molecular mechanisms has demonstrated that lymphatic dysfunction should no longer be considered a passive bystander in disease but rather an active player in many pathological processes and, therefore, a genuine target for future therapeutic developments. The specific roles of the lymphatic system in edema, genetic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn’s disease, obesity, cancer, and cancer-related lymphedema are highlighted.


Url:
DOI: 10.1172/JCI71608
PubMed: 24590276
PubMed Central: 3938261

Links to Exploration step

PMC:3938261

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">New developments in clinical aspects of lymphatic disease</title>
<author>
<name sortKey="Mortimer, Peter S" sort="Mortimer, Peter S" uniqKey="Mortimer P" first="Peter S." last="Mortimer">Peter S. Mortimer</name>
<affiliation>
<nlm:aff id="JCI71608">St. George’s Hospital Medical School, University of London, London, United Kingdom.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G." last="Rockson">Stanley G. Rockson</name>
<affiliation>
<nlm:aff id="JCI71608">Stanford University School of Medicine, Stanford, California, USA.</nlm:aff>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">24590276</idno>
<idno type="pmc">3938261</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3938261</idno>
<idno type="RBID">PMC:3938261</idno>
<idno type="doi">10.1172/JCI71608</idno>
<date when="2014">2014</date>
<idno type="wicri:Area/Pmc/Corpus">004847</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">004847</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">New developments in clinical aspects of lymphatic disease</title>
<author>
<name sortKey="Mortimer, Peter S" sort="Mortimer, Peter S" uniqKey="Mortimer P" first="Peter S." last="Mortimer">Peter S. Mortimer</name>
<affiliation>
<nlm:aff id="JCI71608">St. George’s Hospital Medical School, University of London, London, United Kingdom.</nlm:aff>
</affiliation>
</author>
<author>
<name sortKey="Rockson, Stanley G" sort="Rockson, Stanley G" uniqKey="Rockson S" first="Stanley G." last="Rockson">Stanley G. Rockson</name>
<affiliation>
<nlm:aff id="JCI71608">Stanford University School of Medicine, Stanford, California, USA.</nlm:aff>
</affiliation>
</author>
</analytic>
<series>
<title level="j">The Journal of Clinical Investigation</title>
<idno type="ISSN">0021-9738</idno>
<idno type="eISSN">1558-8238</idno>
<imprint>
<date when="2014">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p>The lymphatic system is fundamentally important to cardiovascular disease, infection and immunity, cancer, and probably obesity — the four major challenges in healthcare in the 21st century. This Review will consider the manner in which new knowledge of lymphatic genes and molecular mechanisms has demonstrated that lymphatic dysfunction should no longer be considered a passive bystander in disease but rather an active player in many pathological processes and, therefore, a genuine target for future therapeutic developments. The specific roles of the lymphatic system in edema, genetic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn’s disease, obesity, cancer, and cancer-related lymphedema are highlighted.</p>
</div>
</front>
</TEI>
<pmc article-type="review-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">J Clin Invest</journal-id>
<journal-id journal-id-type="iso-abbrev">J. Clin. Invest</journal-id>
<journal-id journal-id-type="publisher-id">J CLIN INVEST</journal-id>
<journal-title-group>
<journal-title>The Journal of Clinical Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">0021-9738</issn>
<issn pub-type="epub">1558-8238</issn>
<publisher>
<publisher-name>American Society for Clinical Investigation</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">24590276</article-id>
<article-id pub-id-type="pmc">3938261</article-id>
<article-id pub-id-type="publisher-id">71608</article-id>
<article-id pub-id-type="doi">10.1172/JCI71608</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Series</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>New developments in clinical aspects of lymphatic disease</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mortimer</surname>
<given-names>Peter S.</given-names>
</name>
<xref ref-type="aff" rid="JCI71608">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Rockson</surname>
<given-names>Stanley G.</given-names>
</name>
<xref ref-type="aff" rid="JCI71608">2</xref>
</contrib>
</contrib-group>
<aff id="JCI71608">
<label>1</label>
St. George’s Hospital Medical School, University of London, London, United Kingdom.
<label>2</label>
Stanford University School of Medicine, Stanford, California, USA.</aff>
<author-notes>
<corresp>Address correspondence to: Peter S. Mortimer, St. George’s Hospital Medical School, University of London, London, SW17 ORE, United Kingdom. Phone: 44.0.20.8725.1784; Fax: 44.0.20.8725.5955; E-mail:
<email>mortimer@sgul.ac.uk</email>
. </corresp>
</author-notes>
<pub-date pub-type="epub">
<day>3</day>
<month>3</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub">
<day>3</day>
<month>3</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>1</day>
<month>1</month>
<year>2015</year>
</pub-date>
<pmc-comment> PMC Release delay is 9 months and 29 days and was based on the . </pmc-comment>
<volume>124</volume>
<issue>3</issue>
<fpage>915</fpage>
<lpage>921</lpage>
<permissions>
<copyright-statement>Copyright © 2014, American Society for Clinical Investigation</copyright-statement>
<copyright-year>2014</copyright-year>
</permissions>
<abstract>
<p>The lymphatic system is fundamentally important to cardiovascular disease, infection and immunity, cancer, and probably obesity — the four major challenges in healthcare in the 21st century. This Review will consider the manner in which new knowledge of lymphatic genes and molecular mechanisms has demonstrated that lymphatic dysfunction should no longer be considered a passive bystander in disease but rather an active player in many pathological processes and, therefore, a genuine target for future therapeutic developments. The specific roles of the lymphatic system in edema, genetic aspects of primary lymphedema, infection (cellulitis/erysipelas), Crohn’s disease, obesity, cancer, and cancer-related lymphedema are highlighted.</p>
</abstract>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004847 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 004847 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Pmc
   |étape=   Corpus
   |type=    RBID
   |clé=     PMC:3938261
   |texte=   New developments in clinical aspects of lymphatic disease
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i   -Sk "pubmed:24590276" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024